In the wake of the novel coronavirus outbreak , the biopharmaceutical company with the highest market capitalization change of over nine billion dollars - in the given time range - was Zhejiang Hisun Pharmaceutical as they started phase three trials of their antiviral drug remdesivir for the treatment of COVID-19 .